Regular articles

An ESC/EAPCI consensus statement on renal denervation; a debate on the future of transcatheter mitral valve replacement; a mini focus on interventional pharmacology, from P2Y12 inhibitors to evolocumab; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more

Capodanno D

March 20, 2023

Clopidogrel: still king of the ring for elective percutaneous coronary intervention!

Montalescot G, Ferrante A

March 20, 2023 | 10.4244/EIJ-E-23-00003

Effects of PCSK9 inhibitors on platelet function

Räber L, Ueki Y

March 20, 2023 | 10.4244/EIJ-E-23-00005

Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial

Lansky A, Ahmad Y

March 20, 2023 | 10.4244/EIJ-E-23-00004

Periprocedural adverse events after revascularisation: the importance of getting off to a good start

Gaudino M, Dimagli A

March 20, 2023 | 10.4244/EIJ-E-22-00054

Transcatheter mitral valve replacement will remain a niche therapy: pros and cons

Cohen D, Ludwig S, Piazza N

March 20, 2023 | 10.4244/EIJ-E-22-00044

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Barbato E, Azizi M, Schmieder RE, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari D, Lüscher T, Parati G, Pathak A, Ribichini F, Schlaich M, Sharp A, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F

March 20, 2023 | 10.4244/EIJ-D-22-00723

Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes

Koshy A, Giustino G, Sartori S, Hooda A, Feng Y, Snyder C, Dasgupta S, Kumar K, Krishnamoorthy-Melarcode P, Sweeny J, Khera S, Serrao G, Sharma R, Dangas G, Kini A, Mehran R, Sharma S

March 20, 2023 | 10.4244/EIJ-D-22-00654

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study

Franchi F, Ortega-Paz L, Rollini F, Been L, Rivas A, Maaliki N, Zhou X, Pineda A, Suryadevara S, Soffer D, Zenni M, Angiolillo D

March 20, 2023 | 10.4244/EIJ-D-22-00719

Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry

Gargiulo G, Marenna A, Sperandeo L, Manzi L, Avvedimento M, Simonetti F, Canonico M, Paolillo R, Spinelli A, Borgia F, Diserafino L, Franzone A, Stabile E, Piccolo R, Cirillo P, Valgimigli M, Esposito G

March 20, 2023 | 10.4244/EIJ-D-22-00594

Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study

Kordis P, Bozic Mijovski M, Berden J, Steblovnik K, Blinc A, Noc M

March 20, 2023 | 10.4244/EIJ-D-22-00675

Impact of periprocedural major adverse events on 10-year mortality after revascularisation

Kotoku N, Serruys P, Ninomiya K, Soo A, Masuda S, Kageyama S, Revaiah P, Mack M, Holmes DR, Morice M, Davierwala P, Mohr F, Milojevic M, Kappetein A, Garg S, Onuma Y

March 20, 2023 | 10.4244/EIJ-D-22-00681

Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study

Kawagoe Y, Otsuka F, Onozuka D, Ishibashi-Ueda H, Ikeda Y, Ohta-Ogo K, Matsumoto M, Amemiya K, Asaumi Y, Kataoka Y, Nishimura K, Miyamoto Y, Noguchi T, Finn A, Virmani R, Hatakeyama K, Yasuda S

March 20, 2023 | 10.4244/EIJ-D-22-00650

Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Minten L, Bennett J, Dubois C

March 20, 2023 | 10.4244/EIJ-D-22-00998

Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Sabbah M, Lønborg J, Olsen NT, Engstrøm T

March 20, 2023 | 10.4244/EIJ-D-22-01031

A State-of-the-Art on transcatheter interventions for heart failure; direct wiring pacing for TAVI and PCI; coronary physiology after valve replacement; optimal timing for bioprosthetic valve fracture; an OCT-guided workflow; coronary artery calcification and drug-eluting stents; mechanical thrombectomy for pulmonary embolism; and more

Capodanno D

February 20, 2023

Understanding the mechanism of improved CFR after TAVR/SAVR – the importance of basal flow

Kern M, Seto A

February 20, 2023 | 10.4244/EIJ-E-22-00052

Coronary calcification: you have to crack a few eggs to make an omelette

Sabaté M

February 20, 2023 | 10.4244/EIJ-E-22-00053

Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?

Rheude T, Kufner S

February 20, 2023 | 10.4244/EIJ-E-22-00058

Transcatheter interventions for heart failure

Latib A, Hashim Mustehsan M, Abraham W, Jorde UP, Bartunek J

February 20, 2023 | 10.4244/EIJ-D-22-00070